Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

Innovative Molecules GmbH United Kingdom England Germany Italy United States of America California

View original content:https://www.prnewswire.co.uk/news-releases/innovative-molecules-completes-enrollment-of-phase-1b-clinical-trial-of-im-250-302482334.html